<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: SUPG News</title><copyright>Copyright (c) 2010 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=supg</link><description>Latest Financial News for SuperGen, Inc.</description><language>en-us</language><lastBuildDate>Tue, 5 Jan 2010 11:00:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>SuperGen to Present at Biotech Showcase 2010 on January 12th (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100105/20100105005539.html?.v=1</link><description>DUBLIN, Calif.----SuperGen, Inc. , a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, and Mohammad Azab, M.D., Chief Medical Officer, will present at the Biotech Showcase™ 2010 on Tuesday, January 12th in San Francisco.</description><guid isPermaLink="false">yahoo_finance/2682283229</guid><pubDate>Tue, 5 Jan 2010 11:00:00 Etc/GMT</pubDate></item><item><title>Today&apos;s 5-Star Movers (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12h0sh6j6/*http%3A//www.fool.com/investing/general/2009/12/04/todays-five-star-movers.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/1732355028</guid><pubDate>Fri, 4 Dec 2009 17:45:30 Etc/GMT</pubDate></item><item><title>SuperGen Data Presentations at American Society of Hematology (ASH) Annual Meeting (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091201/20091201005427.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/648795189</guid><pubDate>Tue, 1 Dec 2009 11:00:00 Etc/GMT</pubDate></item><item><title>Biotech Stocks for a Possible Year-End Rally (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12n2vgjjn/*http%3A//seekingalpha.com/article/174153-biotech-stocks-for-a-possible-year-end-rally?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3266256509</guid><pubDate>Wed, 18 Nov 2009 21:41:20 Etc/GMT</pubDate></item><item><title>SUPERGEN INC Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=supg</link><description></description><guid isPermaLink="false">yahoo_finance/3583400471</guid><pubDate>Fri, 13 Nov 2009 14:05:46 Etc/GMT</pubDate></item><item><title>SuperGen to Present at Lazard Healthcare Conference on November 18, 2009 (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091111/20091111005335.html?.v=1</link><description>DUBLIN, Calif.----SuperGen, Inc. , a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18, 2009 in New York.</description><guid isPermaLink="false">yahoo_finance/4108482631</guid><pubDate>Wed, 11 Nov 2009 11:00:00 Etc/GMT</pubDate></item><item><title>SUPERGEN INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091109/supg10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/3953065750</guid><pubDate>Mon, 9 Nov 2009 21:13:41 Etc/GMT</pubDate></item><item><title>SuperGen Presentations at AACR-NCI-EORTC (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091109/20091109005409.html?.v=1</link><description>DUBLIN, Calif.----SuperGen, Inc. , a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of seven abstracts for poster presentations on November 16, 17 and 18, 2009 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, MA.</description><guid isPermaLink="false">yahoo_finance/902037895</guid><pubDate>Mon, 9 Nov 2009 11:00:00 Etc/GMT</pubDate></item><item><title>SuperGen to Present at Merriman Curhan Ford Investor Summit on November 10, 2009 (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091104/20091104005313.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4053648519</guid><pubDate>Wed, 4 Nov 2009 11:00:00 Etc/GMT</pubDate></item><item><title>5-Star Stocks on the Upswing (at Motley Fool)</title><link>http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12mvfegnl/*http%3A//www.fool.com/investing/general/2009/11/02/5-star-stocks-on-the-upswing.aspx?source=eptyholnk303100&amp;logvisit=y&amp;npu=y</link><description></description><guid isPermaLink="false">yahoo_finance/2220978772</guid><pubDate>Mon, 2 Nov 2009 18:37:30 Etc/GMT</pubDate></item><item><title>SUPERGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091028/supg8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3274423667</guid><pubDate>Wed, 28 Oct 2009 20:06:42 Etc/GMT</pubDate></item><item><title>SuperGen Earnings Call scheduled for 4:30 pm ET today (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/4/108384.html</link><description></description><guid isPermaLink="false">yahoo_finance/3988493569</guid><pubDate>Mon, 26 Oct 2009 20:30:00 Etc/GMT</pubDate></item><item><title>SuperGen Reports 2009 Third Quarter Financial Results (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091026/20091026006197.html?.v=1</link><description>DUBLIN, Calif.----SuperGen, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.</description><guid isPermaLink="false">yahoo_finance/2833921294</guid><pubDate>Mon, 26 Oct 2009 20:00:00 Etc/GMT</pubDate></item><item><title>GSK could pay SuperGen more than $375M in cancer-drug deal (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12bp6f07u/*http%3A//triangle.bizjournals.com/triangle/stories/2009/10/26/daily5.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/2189648886</guid><pubDate>Mon, 26 Oct 2009 15:05:15 Etc/GMT</pubDate></item><item><title>Early Movers: Pump Up the Volume (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12pnc9vf2/*http%3A//www.thestreet.com/_yahoo/story/10616657/1/early-movers-pump-up-the-volume.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/3133319441</guid><pubDate>Mon, 26 Oct 2009 12:29:39 Etc/GMT</pubDate></item><item><title>Q3 2009 SuperGen Earnings Release - After Market Close (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091026.html?t=supg</link><description></description><guid isPermaLink="false">yahoo_finance/3911897363</guid><pubDate>Mon, 26 Oct 2009 11:07:23 Etc/GMT</pubDate></item><item><title>Trading Outlook for Peregrine Pharmaceuticals Issued by StockPreacher.com (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091026/176391.html?.v=1</link><description>DALLAS -- StockPreacher.com announces an investment report featuring anti-cancer and antiviral drug developer Peregrine Pharmaceuticals . The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.</description><guid isPermaLink="false">yahoo_finance/2159978801</guid><pubDate>Mon, 26 Oct 2009 10:50:00 Etc/GMT</pubDate></item><item><title>SuperGen receiving $5 million in Glaxo deal (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091026/us_supergen_glaxosmithkline_contract.html?.v=1</link><description>Drug developer SuperGen Inc. said Monday it will receive an initial payment of $5 million, plus a chance for millions more in future payments, under a deal to develop possible cancer therapies with GlaxoSmithKline.</description><guid isPermaLink="false">yahoo_finance/1845197178</guid><pubDate>Mon, 26 Oct 2009 10:45:49 Etc/GMT</pubDate></item><item><title>SuperGen, GlaxoSmithKline sign collaboration deal (at MarketWatch)</title><link>http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7b83EC9471-BCF6-4886-945E-52EE60CDC347%7d&amp;siteid=yhoof2</link><description></description><guid isPermaLink="false">yahoo_finance/1334795226</guid><pubDate>Mon, 26 Oct 2009 10:08:22 Etc/GMT</pubDate></item><item><title>SuperGen and GSK to Collaborate on the Discovery and Development of Novel Epigenetic Therapeutics (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091026/20091026005358.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/912163846</guid><pubDate>Mon, 26 Oct 2009 10:00:00 Etc/GMT</pubDate></item></channel></rss><!-- c18.finance.sp2.yahoo.com compressed/chunked Wed Jan  6 18:25:01 PST 2010 -->
